Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Tesla
TSLA
|
+$3.32B |
| 2 |
Microsoft
MSFT
|
+$280M |
| 3 |
Morgan Stanley
MS
|
+$265M |
| 4 |
American Tower
AMT
|
+$262M |
| 5 |
Charles Schwab
SCHW
|
+$261M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
+$206M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
+$200M |
| 3 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$186M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$151M |
| 5 |
Pfizer
PFE
|
+$132M |
Sector Composition
| 1 | Technology | 24.26% |
| 2 | Healthcare | 13.6% |
| 3 | Financials | 13.04% |
| 4 | Consumer Discretionary | 12.4% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Patrick Industries
PATK
$3.58B
| $23.3M | ﹤0.01% |
511,698
+19,396
| +4% | +$884K |
|
|
BIG
1627
DELISTED
Big Lots, Inc.
BIG
| $23.3M | ﹤0.01% |
542,722
+20,674
| +4% | +$887K |
|
|
AAWW
1628
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $23.3M | ﹤0.01% |
427,127
+24,466
| +6% | +$1.33M |
|
1629
Ligand Pharmaceuticals
LGND
$3.24B
| $23.3M | ﹤0.01% |
374,793
+3,160
| +0.9% | +$196K |
|
1630
Virtu Financial
VIRT
$2.99B
| $23.2M | ﹤0.01% |
921,723
+27,804
| +3% | +$700K |
|
1631
ODP
ODP
$645M
| $23.1M | ﹤0.01% |
788,956
-9,990
| -1% | -$293K |
|
1632
Gray Television
GTN
$572M
| $23.1M | ﹤0.01% |
1,288,826
+38,627
| +3% | +$691K |
|
1633
Health Catalyst
HCAT
$203M
| $23M | ﹤0.01% |
529,435
+42,866
| +9% | +$1.87M |
|
|
VRTU
1634
DELISTED
Virtusa Corporation
VRTU
| $23M | ﹤0.01% |
450,728
+20,900
| +5% | +$1.07M |
|
1635
Newmark Group
NMRK
$3.33B
| $23M | ﹤0.01% |
3,155,887
+493,842
| +19% | +$3.6M |
|
|
KAMN
1636
DELISTED
Kaman Corp
KAMN
| $22.9M | ﹤0.01% |
401,127
+7,186
| +2% | +$411K |
|
|
CVA
1637
DELISTED
Covanta Holding Corporation
CVA
| $22.9M | ﹤0.01% |
1,743,901
+82,163
| +5% | +$1.08M |
|
1638
Mersana Therapeutics
MRSN
$36M
| $22.9M | ﹤0.01% |
34,372
+1,213
| +4% | +$807K |
|
1639
Westamerica Bancorp
WABC
$1.22B
| $22.9M | ﹤0.01% |
413,368
+15,514
| +4% | +$858K |
|
1640
Pennant Group
PNTG
$851M
| $22.8M | ﹤0.01% |
393,269
+13,626
| +4% | +$791K |
|
|
DRNA
1641
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $22.8M | ﹤0.01% |
1,032,838
+88,359
| +9% | +$1.95M |
|
1642
US Physical Therapy
USPH
$1.19B
| $22.8M | ﹤0.01% |
189,203
+64
| +0% | +$7.7K |
|
|
FOCS
1643
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $22.7M | ﹤0.01% |
522,149
+36,725
| +8% | +$1.6M |
|
1644
Cal-Maine
CALM
$5B
| $22.6M | ﹤0.01% |
603,048
+37,433
| +7% | +$1.41M |
|
1645
Myriad Genetics
MYGN
$698M
| $22.6M | ﹤0.01% |
1,143,966
+21,092
| +2% | +$417K |
|
1646
Ocular Therapeutix
OCUL
$2.16B
| $22.6M | ﹤0.01% |
1,090,351
+204,445
| +23% | +$4.23M |
|
|
ADAM
1647
Adamas Trust, Inc. Common Stock
ADAM
$654M
| $22.5M | ﹤0.01% |
1,522,246
+150,373
| +11% | +$2.22M |
|
1648
Park National Corp
PRK
$2.64B
| $22.4M | ﹤0.01% |
213,074
+6,750
| +3% | +$709K |
|
1649
Inovio Pharmaceuticals
INO
$121M
| $22.3M | ﹤0.01% |
210,367
+10,746
| +5% | +$1.14M |
|
1650
Sinclair Inc
SBGI
$971M
| $22.3M | ﹤0.01% |
701,036
+24,239
| +4% | +$772K |
|